Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Advances in metastatic non small cell lung cancer

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 21.10.18
Views: 1526

Dr Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany

Dr Martin Reck talks to ecancer at ESMO 2018 about the latest research for advanced non small cell lung cancer.

He first discusses tyrosine kinase inhibitors, MET alterations, and the improvement of immunotherapies particularly in combination with checkpoint inhibitors.

Dr Reck goes in to more detail about some trials testing these treatments, and potential avenues for the future.

For more on NSCLC, watch Dr Enriqueta Felip discuss advances reported at the conference here.

ecancer's filming has been kindly supported by MSD through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

Related videos

follow us

Donate to ecancer

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation